1. Home
  2. ACV vs RCEL Comparison

ACV vs RCEL Comparison

Compare ACV & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Diversified Income & Convertible Fund of Beneficial Interest

ACV

Virtus Diversified Income & Convertible Fund of Beneficial Interest

HOLD

Current Price

$25.95

Market Cap

272.3M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.52

Market Cap

114.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACV
RCEL
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.3M
114.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACV
RCEL
Price
$25.95
$3.52
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.75
AVG Volume (30 Days)
38.8K
201.4K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
9.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$72,401,000.00
Revenue This Year
N/A
$13.12
Revenue Next Year
N/A
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$16.82
$3.33
52 Week High
$23.74
$14.16

Technical Indicators

Market Signals
Indicator
ACV
RCEL
Relative Strength Index (RSI) 53.11 37.63
Support Level $26.05 $3.33
Resistance Level $26.76 $3.58
Average True Range (ATR) 0.45 0.18
MACD 0.01 0.01
Stochastic Oscillator 53.47 22.31

Price Performance

Historical Comparison
ACV
RCEL

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: